Scotiabank Maintains Sector Outperform on Twist Bioscience, Raises Price Target to $43
Portfolio Pulse from Benzinga Newsdesk
Scotiabank analyst Sung Ji Nam maintains a Sector Outperform rating on Twist Bioscience (TWST) and raises the price target from $30 to $43.
February 05, 2024 | 6:18 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Scotiabank analyst Sung Ji Nam maintains a Sector Outperform rating on Twist Bioscience and raises the price target from $30 to $43.
The upgrade in price target by Scotiabank reflects a positive outlook on Twist Bioscience's future performance. This could lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100